2017 FDA drug approvals: number rebounds but average value slips

被引：1
|
作者：
Baedeker, Mathias [1 ]
Ringel, Michael [2 ]
Panier, Valery [2 ]
Schulze, Ulrik [3 ]
机构：
[1] Boston Consulting Grp Inc, Ludwigstr 21, D-80539 Munich, Germany
[2] Boston Consulting Grp Inc, Exchange Pl,31st Floor, Boston, MA 02109 USA
[3] Boston Consulting Grp Inc, Munstergasse 2, CH-8001 Zurich, Switzerland
来源：
NATURE REVIEWS DRUG DISCOVERY | 2018年 / 17卷 / 02期
关键词：
D O I：
10.1038/nrd.2018.2
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [1] 2017 FDA drug approvals: number rebounds but average value slips
    Mathias Baedeker
    Michael Ringel
    Valery Panier
    Ulrik Schulze
    Nature Reviews Drug Discovery, 2018, 17 : 87 - 87
  • [2] 2018 FDA approvals hit all time high - but average value slips again
    Baedeker, Mathias
    Ringel, Michael
    Schulze, Ulrik
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (02) : 90 - 91
  • [3] 2017 FDA drug approvals
    Mullard A.
    Nature Reviews Drug Discovery, 2018, 17 (2) : 81 - 85
  • [4] Erratum: 2017 FDA drug approvals
    Asher Mullard
    Nature Reviews Drug Discovery, 2018, 17 (2) : 150 - 150
  • [5] Value of 2019 FDA approvals: back to the recent average
    Baedeker, Mathias
    Ringel, Michael
    Schulze, Ulrik
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (02) : 85 - 85
  • [6] FDA Drug Approvals Hit Record Levels in 2017
    Challener, Cynthia A.
    BIOPHARM INTERNATIONAL, 2018, 31 (01) : 12 - 14
  • [7] Value of 2016 FDA drug approvals: reversion to the mean?
    Schulze, Ulrik
    Ringel, Michael
    Panier, Valery
    Baedeker, Mathias
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) : 78 - 78
  • [8] Value of 2016 FDA drug approvals: reversion to the mean?
    Ulrik Schulze
    Michael Ringel
    Valery Panier
    Mathias Baedeker
    Nature Reviews Drug Discovery, 2017, 16 : 78 - 78
  • [9] 2024 FDA approvals exceed average number but have lower sales projections
    Baedeker, Mathias
    Ringel, Michael S.
    Moller, Clemens C.
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (02) : 85 - 85
  • [10] 2017 FDA drug approvals (vol 17, pg 81, 2018)
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (02)
12345